/주식/DERM
DERM

DERM

USD

Journey Medical Corporation Common Stock

$9.000+0.590 (7.015%)

실시간 가격

Healthcare
Drug Manufacturers - Specialty & Generic
미국

가격 차트

Loading Chart...

핵심 지표

시장 지표
기업 기본 정보
거래 통계

시장 지표

시가

$8.410

고가

$9.010

저가

$8.260

거래량

0.22M

기업 기본 정보

시가총액

236.8M

산업

Drug Manufacturers - Specialty & Generic

국가

United States

거래 통계

평균 거래량

0.16M

거래소

NCM

통화

USD

52주 범위

저가 $3.535현재가 $9.000고가 $9.01

관련 뉴스

GlobeNewswire

Journey Medical Corporation Reports Combined Emrosi™ (DFD-29) Phase 3 Clinical Trial Efficacy Data Analysis Presented at the 2025 Fall Clinical Dermatology Conference

FDA-approved Emrosi (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) is available in the United States for the treatment of inflammatory lesions of rosacea

더 보기
Journey Medical Corporation Reports Combined Emrosi™ (DFD-29) Phase 3 Clinical Trial Efficacy Data Analysis Presented at the 2025 Fall Clinical Dermatology Conference
GlobeNewswire

Journey Medical Corporation to Participate in October 2025 Investor Conferences

SCOTTSDALE, Ariz., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation ("Journey Medical" or "the Company") (NASDAQ:DERM), a commercial-stage pharmaceutical company primarily focused on selling and marketing

더 보기
Journey Medical Corporation to Participate in October 2025 Investor Conferences